Adoptive immunotherapy is a new promising treatment for cancer but is associated with severe toxicity mainly related to a capillary leak syndrome. We report the case of a patient with metastatic hypernephroma, who had many complications such as coma, renal failure, pulmonary edema, life-threatening acidosis, cardiac arrhythmias and venous thrombosis. Critical care specialists should be aware of this type of cancer therapy because of multiple side effects requiring ICU supportive care.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan NM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Eng J Med 316:889
Rosenstein M, Ettinghausen SE, Rosenberg SA (1986) Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. J Immunol 137:1735
Papa MZ, Vetto JT, Ettinghausen SE, Mulé SA (1986) Effect of corticosteroid on the antitumor activity of lymphokkine-activated killer cells and interleukin-2 in mice. Cancer Res 46:5618
Vetto JT, Papa MZ, Lotze MT, Chang AE, Rosenberg SA (1987) Reduction of toxicity of interluekin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroids. J Clin Oncol 5:496
Belldegrun A, Webb DE, Austin HA III, Steinberg SM, White DE, Linehan WM, Rosenberg SA (1987) Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer. Ann Intern Med 106:817
About this article
Cite this article
Sculier, J.P., Bron, D., Verboven, J. et al. Multiple organ failure during interleukin-2 administration and LAK cells infusion. Intensive Care Med 14, 666–667 (1988). https://doi.org/10.1007/BF00256776
- Capillary leak syndrome